Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States.
Hultcrantz M, Kleinman D, Vij R, Escalante F, Delforge M, Kotowsky N, Bitetti J, Boytsov N, Camadoo-O'Byrne L, Happ LP, Germain G, Urosevic A, Mahendran M, Duh MS, Laliberte F, Cavo M, Lee HC.
Hultcrantz M, et al. Among authors: duh ms.
Haematologica. 2024 Oct 17. doi: 10.3324/haematol.2024.285893. Online ahead of print.
Haematologica. 2024.
PMID: 39415693
Free article.